Getting Better Results With Semaglutide: What Patients Should Know

Semaglutide has changed how many people think about medical weight management. For some patients, it can reduce appetite, improve blood sugar, and make weight loss more achievable. That does not mean the medication does all the work on its own.

Better results usually come from the full plan around the medication: the right medical evaluation, gradual dosing, nutrition that protects muscle, regular movement, side-effect management, lab monitoring when needed, and follow-up visits. Semaglutide can make change easier to start. The plan helps make it safer and more durable.

First, know which medication you are talking about

Semaglutide is the active ingredient in several prescription medications. The brand name matters because different products have different FDA-approved uses, doses, and prescribing criteria.

Ozempic contains semaglutide and is FDA-approved for adults with type 2 diabetes. It may also reduce the risk of major cardiovascular events in certain adults with type 2 diabetes and established cardiovascular disease.

Wegovy contains semaglutide and is FDA-approved for chronic weight management in certain eligible patients. The FDA label describes it as a treatment used with a reduced-calorie diet and increased physical activity.

That distinction matters. A patient should not assume that one brand, dose, or goal applies to everyone. A clinician can explain which options, if any, fit your medical history.

Set goals that go beyond the scale

Clinical trials show that semaglutide can lead to meaningful weight loss for many patients. In the STEP 1 trial, adults with overweight or obesity who received semaglutide 2.4 mg with lifestyle intervention lost an average of 14.9% of body weight over 68 weeks, compared with 2.4% with placebo.

That number is useful, but it is still an average. Real patients lose weight at different speeds and in different amounts. Some have more nausea. Some lose muscle if nutrition is poor. Some improve blood pressure, blood sugar, or energy before the scale changes much.

Before starting, ask what you will track:

• Weight trend over time
• Waist measurement, if helpful
• Blood pressure
• Blood sugar or A1c when relevant
• Side effects
• Appetite and meal patterns
• Energy, sleep, and daily function
• Strength, balance, and activity tolerance

A good plan looks at weight, side effects, lab results, strength, and daily function.

Do not rush the dose

Semaglutide is usually started low and increased gradually. This is intentional. The goal is to give the body time to adjust and reduce stomach-related side effects.

Do not increase the dose faster than prescribed. Do not double up after a missed dose unless your prescribing clinician tells you to. Do not change the schedule because progress feels slow. If the medication is hard to tolerate, the answer may be slower titration, a pause at the current dose, nutrition changes, or a different plan.

Call the office if side effects are interfering with eating, drinking, work, or sleep.

Eat for nutrition while appetite is lower

One reason semaglutide works is that it can lower appetite. That can help patients eat less. It can also create a new problem: eating too little protein, fiber, fluid, or total nutrition.

When appetite is low, make the first few bites count.

Practical habits to discuss with your clinician:

• Include a protein food at each meal, such as eggs, Greek yogurt, cottage cheese, fish, poultry, tofu, beans, lentils, or a protein shake if needed.
• Eat smaller meals more slowly.
• Stop at comfortable fullness instead of pushing through a large meal.
• Choose fiber-rich foods when tolerated, including vegetables, berries, beans, oats, chia, flax, or whole grains.
• Sip fluids throughout the day.
• Limit greasy, fried, very rich, or very large meals, especially after dose increases.

Protein needs are not the same for everyone. Kidney function, age, activity level, and medical history matter. Ask your clinician what target makes sense for you.

Protect muscle while losing weight

Weight loss can include both fat and lean mass. Preserving muscle matters because muscle supports strength, balance, glucose control, and long-term maintenance.

Medication may reduce appetite, but it does not build strength. That usually takes resistance training and enough protein.

Resistance training does not have to mean a gym. Depending on your ability, it may include:

• Sit-to-stands from a chair
• Wall pushups
• Resistance bands
• Light dumbbells
• Step-ups
• Machines at a gym
• Physical therapy-guided exercise

A common goal is strength work two to three days per week, adjusted for your health and ability. If you have heart disease, severe joint pain, balance problems, or are new to exercise, ask whether you need a physical therapy or exercise referral before starting.

Manage side effects early

Nausea, constipation, diarrhea, reflux, bloating, and reduced appetite are common, especially when starting or increasing the dose. Many side effects improve, but patients should not ignore them.

For nausea, many patients do better with smaller meals, slower eating, bland foods during flare-ups, and avoiding greasy or heavy meals. For constipation, fluids, fiber, walking, and a regular bathroom routine can help. Some patients may need a fiber supplement or constipation medicine, but that should be discussed with a clinician.

Call promptly for:

• Severe or persistent abdominal pain, especially if it moves to the back
• Repeated vomiting
• Inability to keep fluids down
• Very dark urine or much less urination
• Severe constipation, belly swelling, or inability to pass gas or stool
• Yellowing of the skin or eyes
• Symptoms of low blood sugar if you use insulin or a sulfonylurea
• Allergic symptoms such as face, lip, tongue, or throat swelling
• Vision changes, especially if you have diabetes

These symptoms do not mean every patient will have a serious problem. They mean you should not wait at home and guess.

Use follow-up visits to adjust the plan

Follow-up is where the plan gets adjusted. Bring questions about dose timing, side effects, meals, activity, refills, and lab work.

A follow-up may include:

• Review of dose, timing, and missed doses
• Side-effect check
• Weight and blood pressure trend
• Medication list review
• Blood sugar or A1c review when relevant
• Kidney function or other labs when clinically appropriate
• Nutrition and protein review
• Activity and strength plan
• Coverage or prior authorization updates
• Discussion of whether the medication is still appropriate

The Endocrine Society recommends checking safety and effectiveness at least monthly for the first three months of weight-loss medication treatment, then at least every three months. Your schedule may be different depending on diabetes, side effects, dose changes, or other medical conditions.

Plan for plateaus

A plateau does not always mean the medication stopped working. Weight loss often slows as the body adapts. Calorie needs change. Appetite may return in smaller ways. Stress, sleep, alcohol, snacking, missed doses, constipation, and other medications can all affect progress.

When progress slows, review the basics before assuming the treatment failed:

• Are you getting enough protein?
• Are you drinking enough fluid?
• Are you eating very little during the day and more at night?
• Are liquid calories, alcohol, or grazing sneaking in?
• Has activity dropped because of fatigue or nausea?
• Are you doing any strength work?
• Are sleep or stress affecting appetite?
• Are other medications contributing to weight gain?

Avoid crash dieting during a plateau. It can worsen fatigue, constipation, gallstone risk, and muscle loss.

Think about maintenance before stopping

Semaglutide treats a chronic condition for many patients. When it is stopped, weight regain is common.

In a STEP 1 extension study, participants regained about two-thirds of the weight they had lost within one year after stopping semaglutide, and several cardiometabolic improvements moved back toward baseline. In the STEP 4 trial, people who continued semaglutide after an initial treatment period kept losing weight, while those switched to placebo regained weight on average.

This does not mean every person must stay on medication forever. It means maintenance should be planned. Before stopping or tapering, talk through appetite changes, nutrition, activity, weight trend, lab results, coverage, and what support will stay in place.

What to bring to a medical weight-management visit

Bring:

• Insurance card
• Photo ID
• Current medication list, including supplements
• Recent lab results, if you have them
• Diabetes supplies or glucose readings, if you use them
• A list of side effects or concerns
• Questions about coverage, cost, dosing, and follow-up

If you are not sure whether insurance covers a visit or medication, bring your card and call the office. Coverage varies by plan, diagnosis, prior authorization rules, and pharmacy availability.

The main takeaway

Semaglutide can be a helpful tool for some patients. The strongest plan is usually not built around medication alone. It includes follow-up, nutrition, strength, side-effect management, safety monitoring, and maintenance planning.

Interested in medical weight-management support? Book a medical weight-loss visit or call Moses Medical at (646) 741-2111. Bring your insurance card, medication list, and any recent labs so the team can review your next step.

References

• U.S. Food and Drug Administration. Wegovy prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215256s026lbl.pdf
• DailyMed. Ozempic prescribing information. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
• Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
• Rubino D, Abrahamsson N, Davies M, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity. JAMA. https://jamanetwork.com/journals/jama/fullarticle/2777886
• Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide. PubMed. https://pubmed.ncbi.nlm.nih.gov/35441470/
• Endocrine Society. Pharmacological management of obesity clinical practice guideline. https://academic.oup.com/jcem/article/100/2/342/2813109
• American Diabetes Association. Standards of Care in Diabetes, Obesity and Weight Management. https://diabetesjournals.org/care/article/48/Supplement_1/S167/157555/8-Obesity-and-Weight-Management-for-the-Prevention
• American Journal of Clinical Nutrition. Nutritional priorities to support GLP-1 therapy. https://ajcn.nutrition.org/article/S0002-9165(25)00240-0/fulltext